Nanobiotix is a publicly traded company trading on NASDAQ, led by CEO Laurent Levy.
No upcoming earnings scheduled for Nanobiotix
No earnings announcement scheduled
Past 11 earnings reports for Nanobiotix
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | FY 2025 | -$0.58 | — | $37.9MEst: $165.5M | -77.1% | — |
| Sep 30, 2025 | H1 2025 | -$0.12 | — | $30.2M | — | — |
| Apr 2, 2025 | FY 2024 | $1.56 | — | $13.1M | — | — |
| Sep 18, 2024 | H1 2024 | -$0.50 | — | $10.0M | — | — |
| Apr 24, 2024 | FY 2023 | -$1.17 | — | $39.3M | — | — |
| Sep 26, 2023 | H1 2023 | -$0.87 | — | $3.6M | — | — |
| Apr 24, 2023 | FY 2022 | -$1.73 | — | $5.0M | — | — |
| Sep 28, 2022 | H1 2022 | -$0.83 | — | $1.5M | — | — |
| Mar 30, 2022 | FY 2021 | -$1.54 | — | $3.0M | — | — |
| Sep 8, 2021 | H1 2021 | -$1.06 | — | $1.6M | — | — |
| Feb 26, 2021 | FY 2020 | -$1.60 | — | $2.9M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.